CAPR Investor Reminder: Capricor Therapeutics Securities Fraud Class Action after 64% Stock Drop is Pending – Investors Notified to Contact BFA Law before September 28 Deadline
Bleichmar Fonti & Auld LLP (BFA Law) is soliciting Capricor Therapeutics investors ahead of a September 28, 2026 lead plaintiff deadline in a pending securities fraud class action, Nkamga v. Capricor Therapeutics, Inc. et al., No. 26-cv-04385, in the U.S.
Key figures
- Court
- U.S. District Court for the Southern District of California
- Adcomm vote
- 9-3 against efficacy
- Case number
- No. 26-cv-04385
- Second drop pct
- 36%
- Stock drop date
- July 27, 2026
- Close after drop
- 7
- Close before drop
- 19.7
- Alleged stock drop pct
- 64.5%
- Close after adcomm vote
- 4.19
- Lead plaintiff deadline
- September 28, 2026
- Per share decline first
- $12.70
- Per share decline second
- $2.38
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.